{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:44:55Z","timestamp":1789771495611,"version":"4.0.1"},"reference-count":83,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T00:00:00Z","timestamp":1578528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2019.00888","type":"journal-article","created":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T23:22:10Z","timestamp":1578525730000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Hypothyroidism: Cardiovascular Endpoints of Thyroid Hormone Replacement"],"prefix":"10.3389","volume":"10","author":[{"given":"Angeliki","family":"Stamatouli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Bedoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahzene","family":"Yavuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,1,9]]},"reference":[{"key":"B1","first-page":"D926","article-title":"What is a normal thyroid function?","volume":"161","author":"Chaker","year":"2017","journal-title":"Ned Tijdschr Geneeskd"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1001\/jama.2010.1786","article-title":"Subclinical hypothyroidism and the risk of coronary heart disease and mortality","volume":"304","author":"Rodondi","year":"2010","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2003.10.033","article-title":"Mechanisms of thyroid hormone receptor\u2013specific nuclear and extra nuclear actions","volume":"213","author":"Bassett","year":"2003","journal-title":"Mol Cell Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/j.jacc.2018.02.045","article-title":"Thyroid hormones and cardiovascular function and diseases","volume":"71","author":"Razvi","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.hfc.2019.02.008","article-title":"The management of thyroid abnormalities in chronic heart failure","volume":"15","author":"Biondi","year":"2019","journal-title":"Heart Fail Clin"},{"key":"B6","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1507\/endocrj.K11E-012","article-title":"Multi-center study on the prevalence of hypothyroidism in patients with hypercholesterolemia","volume":"58","author":"Tagami","year":"2011","journal-title":"Endocr J"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/EP.18.S1.1","article-title":"American Association of Clinical Endocrinologists' guidelines for management of dyslipidemia and prevention of atherosclerosis","volume":"18","author":"Jellinger","year":"2012","journal-title":"Endocr Pract"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1001\/archinte.160.11.1573","article-title":"American Thyroid Association guidelines for detection of thyroid dysfunction","volume":"160","author":"Ladenson","year":"2000","journal-title":"Arch Intern Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1001\/jamainternmed.2013.12188","article-title":"Thyroid function testing in patients with newly diagnosed hyperlipidemia","volume":"174","author":"Willard","year":"2014","journal-title":"JAMA Intern Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/S0025-6196(12)60694-6","article-title":"Hyperlipidemia in patients with primary and secondary hypothyroidism","volume":"68","author":"O'Brien","year":"1993","journal-title":"Mayo Clin Proc"},{"key":"B11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1210\/jcem.76.1.8421075","article-title":"Lipoprotein(a) and apolipoprotein B plasma concentrations in hypothyroid, euthyroid, and hyperthyroid subjects","volume":"76","author":"de Bruin","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1210\/jcem.80.2.7852521","article-title":"Long-term thyroid replacement therapy and levels of lipoprotein(a) and other lipoproteins","volume":"80","author":"Pazos","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1073\/pnas.78.4.2591","article-title":"Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo","volume":"78","author":"Thompson","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"B14","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/S0026-0495(96)90131-6","article-title":"Growth hormone normalizes low-density lipoprotein receptor gene expression in hypothyroid rats","volume":"45","author":"Hoogerbrugge","year":"1996","journal-title":"Metabolism"},{"key":"B15","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1161\/01.ATV.18.5.732","article-title":"Effect of thyroid function on LDL oxidation","volume":"18","author":"Costantini","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1172\/JCI107017","article-title":"Plasma triglyceride metabolism in thyroid disease","volume":"51","author":"Nikkila","year":"1972","journal-title":"J Clin Invest"},{"key":"B17","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1055\/s-2007-1011728","article-title":"Hepatic lipase and the clearing reaction: studies in euthyroid and hypothyroid subjects","volume":"19","author":"Valdemarsson","year":"1987","journal-title":"Horm Metab Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1089\/thy.2009.0212","article-title":"Decreased lipid intermediate levels and lipid oxidation rates despite normal lipolysis in patients with hypothyroidism","volume":"20","author":"Gjedde","year":"2010","journal-title":"Thyroid"},{"key":"B19","first-page":"513","article-title":"High-density lipoprotein cholesterol, hepatic lipase and lipoprotein lipase activities in thyroid dysfunction-effects of treatment","volume":"59","author":"Lam","year":"1986","journal-title":"Q J Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1365-2362.1990.tb01904.x","article-title":"The activity of cholesteryl ester transfer protein is decreased in hypothyroidism: a possible contribution to alterations in high-density lipoproteins","volume":"20","author":"Dullaart","year":"1990","journal-title":"Eur J Clin Invest"},{"key":"B21","doi-asserted-by":"publisher","first-page":"76","DOI":"10.2174\/1874192401105010076","article-title":"Effects of thyroid dysfunction on lipid profile","volume":"5","author":"Rizos","year":"2011","journal-title":"Open Cardiovasc Med J"},{"key":"B22","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1046\/j.1365-2265.2003.01762.x","article-title":"Serum concentrations of remnant-like particles in hypothyroid patients before and after thyroxine replacement","volume":"58","author":"Ito","year":"2003","journal-title":"Clin Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1089\/thy.2000.10.803","article-title":"Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment","volume":"10","author":"Tzotzas","year":"2000","journal-title":"Thyroid"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/0026-0495(95)90075-6","article-title":"Effect of L-thyroxine therapy on lipoprotein fractions in overt and subclinical hypothyroidism, with special reference to lipoprotein(a)","volume":"44","author":"Arem","year":"1995","journal-title":"Metabolism"},{"key":"B25","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/0026-0495(92)90176-B","article-title":"Treatment of hypothyroidism reduces low-density lipoproteins but not lipoprotein(a)","volume":"41","author":"Klausen","year":"1992","journal-title":"Metabolism"},{"key":"B26","doi-asserted-by":"publisher","first-page":"245","DOI":"10.14310\/horm.2002.1274","article-title":"Combined therapy with L-thyroxine and L-triiodothyronine compared to L-thyroxine alone in the treatment of primary hypothyroidism","volume":"9","author":"Fadeyev","year":"2010","journal-title":"Hormones"},{"key":"B27","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1590\/2359-3997000000192","article-title":"Treatment of hypothyroidism with levothyroxine plus liothyronine: a randomized, double-blind, crossover study","volume":"60","author":"Kaminski","year":"2016","journal-title":"Arch Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1080\/07435800903156340","article-title":"Efficacy of combined levothyroxine and liothyronine as compared with Levothyroxine monotherapy in primary hypothyroidism: a randomized controlled trial","volume":"34","author":"Valizadeh","year":"2009","journal-title":"Endocr Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1001\/jama.290.22.2952","article-title":"Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial","volume":"290","author":"Clyde","year":"2003","journal-title":"JAMA"},{"key":"B30","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1056\/NEJM199902113400603","article-title":"Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism","volume":"340","author":"Bunevicius","year":"1999","journal-title":"N Engl J Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1210\/jc.2006-0448","article-title":"Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta-analysis of randomized controlled trials","volume":"91","author":"Grozinsky-Glasberg","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1210\/jcem.87.4.8378","article-title":"Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study","volume":"87","author":"Caraccio","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","doi-asserted-by":"publisher","first-page":"4860","DOI":"10.1210\/jcem.86.10.7973","article-title":"TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study)","volume":"86","author":"Meier","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B34","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1530\/eje.0.1380141","article-title":"High serum cholesterol levels in persons with 'high-normal' TSH levels: should one extend the definition of subclinical hypothyroidism?","volume":"138","author":"Michalopoulou","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1089\/thy.2014.0219","article-title":"Subclinical hypothyroidism might worsen the effects of aging on serum lipid profiles: a population-based case-control study","volume":"25","author":"Zhao","year":"2015","journal-title":"Thyroid"},{"key":"B36","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.metabol.2017.07.006","article-title":"Thyroid stimulating hormone exhibits the impact on LDLR\/LDL-c via up-regulating hepatic PCSK9 expression","volume":"76","author":"Gong","year":"2017","journal-title":"Metabolism"},{"key":"B37","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.dsx.2018.08.021","article-title":"The influence of subclinical hypothyroidism on serum lipid profile, PCSK9 levels and CD36 expression on monocytes","volume":"13","author":"Fazaeli","year":"2019","journal-title":"Diabetes Metab Syndr"},{"key":"B38","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1365-2265.1988.tb03651.x","article-title":"LDL\/HDL-changes in subclinical hypothyroidism: possible risk factors for coronary heart disease","volume":"28","author":"Althaus","year":"1988","journal-title":"Clin Endocrinol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1365-2265.1990.tb03889.x","article-title":"Decreased HDL cholesterol in subclinical hypothyroidism: the effect of L-thyroxine therapy","volume":"33","author":"Caron","year":"1990","journal-title":"Clin Endocrinol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/S0002-9343(02)01022-7","article-title":"A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism","volume":"112","author":"Kong","year":"2002","journal-title":"Am J Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1210\/jcem.85.9.6841","article-title":"Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature","volume":"85","author":"Danese","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1210\/jc.2003-031669","article-title":"Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo-controlled study","volume":"89","author":"Monzani","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B43","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1210\/jc.2006-1605","article-title":"Effect of levo\u2013thyroxine replacement on non-high-density lipoprotein cholesterol in hypothyroid patients","volume":"92","author":"Ito","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"B44","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.amjmed.2004.04.027","article-title":"Disturbed metabolism of remnant lipoproteins in patients with subclinical hypothyroidism","volume":"117","author":"Ito","year":"2004","journal-title":"Am J Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1089\/105072502320908349","article-title":"Circulating levels of oxidized low\u2013density lipoprotein in overt and mild hypothyroidism","volume":"12","author":"Duntas","year":"2002","journal-title":"Thyroid"},{"key":"B46","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1210\/jc.2011-2532","article-title":"Update in lipid alterations in subclinical hypothyroidism","volume":"97","author":"Pearce","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1093\/eurheartj\/ehq185","article-title":"Imaging of atherosclerosis: carotid intima-media thickness","volume":"31","author":"O'Leary","year":"2010","journal-title":"Eur Heart J."},{"key":"B48","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s11883-012-0306-4","article-title":"The role of carotid intimal thickness testing and risk prediction in the development of coronary atherosclerosis","volume":"15","author":"Darabian","year":"2013","journal-title":"Curr Atheroscler Rep"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e016053","DOI":"10.1136\/bmjopen-2017-016053","article-title":"Effect of levothyroxine on the progression of carotid intima-media thickness in subclinical hypothyroidism patients: a meta-analysis","volume":"7","author":"Zhao","year":"2017","journal-title":"BMJ Open"},{"key":"B50","doi-asserted-by":"publisher","first-page":"643","DOI":"10.5551\/jat.39917","article-title":"Effect of thyroxin treatment on carotid intima-media thickness (CIMT) reduction in patients with subclinical hypothyroidism (SCH): a meta-analysis of clinical trials","volume":"24","author":"Aziz","year":"2017","journal-title":"J Atheroscler Thromb"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1530\/EC-18-0194","article-title":"Endothelial dysfunction and the risk of atherosclerosis in overt and subclinical hypothyroidism","volume":"7","author":"Saif","year":"2018","journal-title":"Endocr Connect"},{"key":"B52","doi-asserted-by":"publisher","first-page":"216","DOI":"10.5551\/jat.30338","article-title":"Free triiodothyronine concentrations are inversely associated with elevated carotid intima-media thickness in middle-aged and elderly Chinese population","volume":"23","author":"Zhou","year":"2016","journal-title":"J Atheroscler Thromb"},{"key":"B53","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/j.1365-2265.2007.02943.x","article-title":"Carotid artery intima media thickness is inversely related to serum free thyroxine in euthyroid subjects","volume":"67","author":"Dullaart","year":"2007","journal-title":"Clin Endocrinol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.numecd.2015.09.001","article-title":"No evidence of association between subclinical thyroid disorders and common carotid intima medial thickness or atherosclerotic plaque","volume":"25","author":"Delitala","year":"2015","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1210\/jc.2018-00279","article-title":"Impact of thyroid hormone therapy on atherosclerosis in the elderly with subclinical hypothyroidism: a randomized trial","volume":"103","author":"Blum","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B56","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0140-6736(05)17741-1","article-title":"Global burden of hypertension: analysis of worldwide data","volume":"365","author":"Kearney","year":"2005","journal-title":"Lancet"},{"key":"B57","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1210\/endo-15-4-265","article-title":"The high incidence of hypertension in toxic goiter and in myxedema","volume":"15","author":"Kearney","year":"1931","journal-title":"Endocrinology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1365-2265.2005.02301.x","article-title":"Ambulatory blood pressure monitoring in patients with hyperthyroidism before and after control of thyroid function","volume":"63","author":"Iglesias","year":"2005","journal-title":"Clin Endocrinol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1038\/hr.2011.91","article-title":"Blood pressure levels in patients with subclinical thyroid dysfunction: a meta-analysis of cross-sectional data","volume":"34","author":"Cai","year":"2011","journal-title":"Hypertens Res"},{"key":"B60","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1210\/jc.2006-2208","article-title":"Association between blood pressure and serum thyroid-stimulating hormone concentration within the reference range: a population-based study","volume":"92","author":"Asvold","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B61","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/AOG.0b013e318240de6a","article-title":"Subclinical thyroid disease and the incidence of hypertension in pregnancy","volume":"119","author":"Wilson","year":"2012","journal-title":"Obstet Gynecol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1161\/HYPERTENSIONAHA.118.10971","article-title":"Nocturnal hypertension: new technology and evidence","volume":"71","author":"Kario","year":"2018","journal-title":"Hypertension"},{"key":"B63","doi-asserted-by":"publisher","first-page":"S997","DOI":"10.1016\/j.dsx.2017.07.028","article-title":"Reversal of nocturnal non-dipping of blood pressure after Levothyroxine therapy in patients with subclinical hypothyroidism","volume":"11","author":"Nath","year":"2017","journal-title":"Diabetes Metab Syndr"},{"key":"B64","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3389\/fendo.2018.00454","article-title":"Effect of levothyroxine on blood pressure in patients with subclinical hypothyroidism: a systematic review and meta-analysis","volume":"9","author":"He","year":"2018","journal-title":"Front Endocrinol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1056\/NEJMoa1603825","article-title":"Thyroid hormone therapy for older adults with subclinical hypothyroidism","volume":"377","author":"Stott","year":"2017","journal-title":"N Engl J Med"},{"key":"B66","doi-asserted-by":"publisher","first-page":"4543","DOI":"10.1210\/jc.2003-030249","article-title":"Combined thyroxine\/liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism","volume":"88","author":"Walsh","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B67","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1210\/jc.2004-1672","article-title":"Partial substitution of thyroxine (T4) with tri-iodothyronine in patients on T4 replacement therapy: results of a large community-based randomized controlled trial","volume":"90","author":"Saravanan","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1016\/j.ijcard.2009.01.012","article-title":"Developing thyroid disorders is associated with poor prognosis factors in patient with stable chronic heart failure","volume":"147","author":"Silva-Tinoco","year":"2011","journal-title":"Int J Cardiol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jchf.2012.10.004","article-title":"Thyroid function in heart failure and impact on mortality","volume":"1","author":"Mitchell","year":"2013","journal-title":"JACC Heart Fail"},{"key":"B70","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/MAJ.0000000000000524","article-title":"Free triiodothyronine levels and short-term prognosis in chronic heart failure patients with type 2 diabetes","volume":"350","author":"Chen","year":"2015","journal-title":"Am J Med Sci"},{"key":"B71","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.amjcard.2016.10.045","article-title":"Usefulness of serum triiodothyronine (T3) to predict outcomes in patients hospitalized with acute heart failure","volume":"119","author":"Rothberger","year":"2017","journal-title":"Am J Cardiol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.amjmed.2004.07.052","article-title":"Triiodothyronine levels for risk stratification of patients with chronic heart failure","volume":"118","author":"Pingitore","year":"2005","journal-title":"Am J Med"},{"key":"B73","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1089\/thy.2016.0570","article-title":"Myocardial induction of type 3 deiodinase in dilated cardiomyopathy","volume":"27","author":"Wassner","year":"2017","journal-title":"Thyroid"},{"key":"B74","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1159\/000469708","article-title":"Cardiac thyroid hormone metabolism and heart failure","volume":"6","author":"Janssen","year":"2017","journal-title":"Eur Thyroid J"},{"key":"B75","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1161\/CIRCULATIONAHA.108.834424","article-title":"DITPA (3,5\u2013Diiodothyropropionic Acid), a thyroid hormone analog to treat heart failure: phase II trial veterans affairs cooperative study","volume":"119","author":"Goldman","year":"2009","journal-title":"Circulation"},{"key":"B76","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/cen.12648","article-title":"Long-term L-Triiodothyronine (T3) treatment in stable systolic heart failure patients: a randomised, double-blind, cross-over, placebo-controlled intervention study","volume":"83","author":"Holmager","year":"2015","journal-title":"Clin Endocrinol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1210\/er.2006-0043","article-title":"The clinical significance of subclinical thyroid dysfunction","volume":"29","author":"Biondi","year":"2008","journal-title":"Endocr Rev"},{"key":"B78","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1001\/jama.2019.9052","article-title":"Subclinical hypothyroidism: a review","volume":"322","author":"Biondi","year":"2019","journal-title":"JAMA"},{"key":"B79","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.cjca.2017.10.021","article-title":"Subclinical hypothyroidism is associated with adverse prognosis in heart failure patients","volume":"34","author":"Sato","year":"2018","journal-title":"Can J Cardiol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1161\/CIRCULATIONAHA.112.096024","article-title":"Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts","volume":"126","author":"Gencer","year":"2012","journal-title":"Circulation"},{"key":"B81","doi-asserted-by":"publisher","first-page":"e005266","DOI":"10.1161\/CIRCHEARTFAILURE.118.005266","article-title":"Thyroid dysfunction in heart failure and cardiovascular outcomes","volume":"11","author":"Kannan","year":"2018","journal-title":"Circ Heart Fail"},{"key":"B82","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.endoen.2013.10.013","article-title":"Improvement in functional capacity after levothyroxine treatment in patients with chronic heart failure and subclinical hypothyroidism","volume":"60","author":"Curotto Grasiosi","year":"2013","journal-title":"Endocrinol Nutr."},{"key":"B83","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13063-019-3219-5","article-title":"Efficacy and safety of levothyroxine (L-T4) replacement on the exercise capability in chronic systolic heart failure patients with subclinical hypothyroidism: study protocol for a multi-center, open label, randomized, parallel group trial (ThyroHeart-CHF)","volume":"20","author":"Zhang","year":"2019","journal-title":"Trials"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00888\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T23:22:12Z","timestamp":1578525732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00888\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,9]]},"references-count":83,"alternative-id":["10.3389\/fendo.2019.00888"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2019.00888","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,9]]},"article-number":"888"}}